+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Metabolomics Market by Component, Indication, Application, End-User - Global Forecast to 2030- Product Image
Metabolomics Market by Component, Indication, Application, End-User - Global Forecast to 2030- Product Image
Sale

Metabolomics Market by Component, Indication, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674898
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The metabolomics market is rapidly evolving, with demand driven by greater integration of advanced analytics, new instrument technologies, and shifts in strategic research priorities. As organizations reimagine their scientific portfolios and investment approaches, clarity on this sector’s progression is essential for senior leaders steering R&D or commercial strategy.

Metabolomics Market Snapshot

The metabolomics market grew from USD 3.05 billion in 2024 to USD 3.39 billion in 2025. It is expected to continue growing at a CAGR of 11.38%, reaching USD 5.83 billion by 2030. This sector’s momentum reflects rising adoption of metabolomics in both clinical and research environments, spanning translational research applications and commercial biotech development. Key contributors include increased use of high-throughput platforms, bioinformatics, and greater collaboration between industry and academia, particularly for disease biomarker identification and precision medicine initiatives.

Scope & Segmentation of the Metabolomics Market

Comprehensive market segmentation provides actionable insights for stakeholders seeking clarity in investment planning and new business development. Coverage includes:

  • Components: Bioinformatics tools and services supporting customized analytics; a broad spectrum of metabolomics instruments divided into detection and separation technologies such as mass spectrometry, NMR spectroscopy, and surface-based mass analysis.
  • Indications: Cardiovascular, metabolic, neurological, and oncological disorder research, each with unique analytical requirements and end-user priorities.
  • Applications: Biomarker discovery for various disease classes, drug discovery including pathway mapping and target identification, environmental science for chemical residue analysis, nutrigenomics for nutrition and health insights, personalized medicine leveraging genomic correlations, and toxicology testing focused on safety evaluation.
  • End Users: Academic research institutes developing foundational science, contract research organizations managing outsourced studies, and pharmaceutical or biotech companies integrating findings into R&D pipelines.
  • Geographic Regions:
    • Americas: United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina.
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland.
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan.
  • Leading Companies: The landscape features established and emerging players such as Afekta Technologies, BASF SE, Biocrates Life Science, Bruker, Danaher, Metabolon, Thermo Fisher Scientific, Waters, and others.

Key Takeaways for Senior Decision-Makers

  • Accelerated integration of innovative instrument platforms and bioinformatics is producing richer and more actionable metabolite data for life science studies, pharmaceutical development, and diagnostics.
  • Democratization of high-resolution techniques is reducing barriers, enabling broader adoption in both established and emerging research hubs worldwide.
  • Translational partnerships and public-private collaborations are enabling more rapid progression from discovery to clinical utility, especially in fields like oncology, neurology, and cardiovascular research.
  • Providers are increasingly delivering modular solutions that incorporate both laboratory workflows and cloud-based analytics, which help organizations control capital expenditure and flexibly address new project demands.
  • Regulatory agencies are increasingly recognizing metabolomics data, motivating companies to realign R&D and compliance strategies toward harmonized and innovation-friendly workflows.
  • Supply chain vulnerabilities are addressed through diversified sourcing and enhanced local assembly; these are influencing strategic procurement and the pace of platform upgrades.

Tariff Impact: 2025 US Developments in Metabolomics

Recent US tariffs have introduced new cost variables for global metabolomics equipment manufacturers. Organizations are evaluating alternative sourcing and in-country assembly as proactive measures to mitigate input cost increases. End users are balancing budget management with the imperative to maintain leading-edge analytical capabilities, sometimes opting for refurbished or alternative solutions. Ongoing policy dialogues and trade alliances aim to stabilize tariff influences and sustain research continuity.

Methodology & Data Sources

This research synthesizes secondary sources—such as published journals, patents, and regulatory filings—with primary interviews from domain experts. Triangulated data analysis ensures a holistic perspective on technology, adoption challenges, and commercial opportunities.

Why This Report Matters

  • Enables targeted, data-driven investment decisions by mapping relevant market drivers, emerging technologies, and high-potential regions within the metabolomics sector.
  • Supports strategic planning by linking evolving application needs, regional funding climates, and the activities of leading organizations—empowering leaders to prioritize what matters most.

Conclusion

The metabolomics market presents a dynamic environment shaped by technology convergence, regulatory innovation, and expanding collaborative models. Senior leaders can leverage these insights to guide resource allocation, partnership strategies, and future-ready R&D priorities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Metabolomics Market, by Component
8.1. Introduction
8.2. Bioinformatics Tools & Services
8.2.1. Bioinformatics Services
8.2.2. Bioinformatics Tools & Databases
8.3. Metabolomic Instruments
8.3.1. Detection Tools
8.3.1.1. Mass Spectrometry
8.3.1.2. Nuclear Magnetic Resonance Spectroscopy
8.3.1.3. Surface-based Mass Analysis
8.3.2. Separation Tools
8.3.2.1. Capillary Electrophoresis
8.3.2.2. Gas Chromatography
8.3.2.3. High-Performance Liquid Chromatography
8.3.2.4. Ultra Performance Liquid Chromatography
9. Metabolomics Market, by Indication
9.1. Introduction
9.2. Cardiovascular Disorders
9.3. Metabolic Disorders
9.4. Neurological Disorders
9.5. Oncological Disorders
10. Metabolomics Market, by Application
10.1. Introduction
10.2. Biomarker Discovery
10.2.1. Cancer Biomarkers
10.2.2. Neurological Biomarkers
10.3. Drug Discovery
10.3.1. Metabolic Pathways
10.3.2. Target Identification
10.4. Environmental Science
10.4.1. Pesticide Residue Analysis
10.4.2. Water Quality Analysis
10.5. Nutrigenomics
10.5.1. Cardiovascular Health
10.5.2. Obesity Research
10.6. Personalized Medicine
10.6.1. Genomic Studies
10.6.2. Therapeutic Monitoring
10.7. Toxicology Testing
11. Metabolomics Market, by End-User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Contract Research Organizations
11.4. Pharmaceutical & Biotechnology Companies
12. Americas Metabolomics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Metabolomics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Metabolomics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Afekta Technologies Ltd.
15.3.2. BASF SE
15.3.3. Bio-Rad Laboratories, Inc.
15.3.4. Biocrates Life Science AG
15.3.5. Bruker Corporation
15.3.6. Clinical Microbiomics A/S
15.3.7. Danaher Corporation
15.3.8. DNA Xperts Private Limited
15.3.9. General Metabolics
15.3.10. Hitachi High-Tech Corporation
15.3.11. Human Metabolome Technologies Inc.
15.3.12. JASCO Corporation
15.3.13. Kore Technology Limited
15.3.14. LECO Corporation
15.3.15. Merck KGaA
15.3.16. Metabolon, Inc.
15.3.17. Shimadzu Corporation
15.3.18. Techcomp Europe Ltd
15.3.19. Thermo Fisher Scientific Inc.
15.3.20. Waters Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. METABOLOMICS MARKET MULTI-CURRENCY
FIGURE 2. METABOLOMICS MARKET MULTI-LANGUAGE
FIGURE 3. METABOLOMICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL METABOLOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL METABOLOMICS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL METABOLOMICS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL METABOLOMICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL METABOLOMICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. METABOLOMICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. METABOLOMICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. METABOLOMICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & DATABASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL METABOLOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL METABOLOMICS MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL METABOLOMICS MARKET SIZE, BY SURFACE-BASED MASS ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL METABOLOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL METABOLOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL METABOLOMICS MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL METABOLOMICS MARKET SIZE, BY ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL METABOLOMICS MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL METABOLOMICS MARKET SIZE, BY CANCER BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC PATHWAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL METABOLOMICS MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL METABOLOMICS MARKET SIZE, BY PESTICIDE RESIDUE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL METABOLOMICS MARKET SIZE, BY WATER QUALITY ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL METABOLOMICS MARKET SIZE, BY OBESITY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL METABOLOMICS MARKET SIZE, BY GENOMIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL METABOLOMICS MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL METABOLOMICS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL METABOLOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL METABOLOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL METABOLOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 83. CANADA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 84. CANADA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 85. CANADA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 86. CANADA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 87. CANADA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 88. CANADA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. CANADA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. CANADA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 91. CANADA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 92. CANADA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 93. CANADA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 94. CANADA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 95. CANADA METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. MEXICO METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 97. MEXICO METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 98. MEXICO METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. MEXICO METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. MEXICO METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 104. MEXICO METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 105. MEXICO METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 106. MEXICO METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 107. MEXICO METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. GERMANY METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 163. GERMANY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 164. GERMANY METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 165. GERMANY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 166. GERMANY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 167. GERMANY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 168. GERMANY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. GERMANY METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 170. GERMANY METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 171. GERMANY METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 172. GERMANY METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 173. GERMANY METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 174. GERMANY METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. FRANCE METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 176. FRANCE METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 177. FRANCE METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 178. FRANCE METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 179. FRANCE METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 180. FRANCE METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. FRANCE METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. FRANCE METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 183. FRANCE METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 184. FRANCE METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 185. FRANCE METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 186. FRANCE METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 187. FRANCE METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. ITALY METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 202. ITALY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 203. ITALY METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 204. ITALY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 205. ITALY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 206. ITALY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 207. ITALY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. ITALY METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 209. ITALY METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 210. ITALY METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 211. ITALY METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 212. ITALY METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 213. ITALY METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. SPAIN METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 215. SPAIN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 216. SPAIN METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 217. SPAIN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 218. SPAIN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 219. SPAIN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 220. SPAIN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. SPAIN METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 222. SPAIN METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 223. SPAIN METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 224. SPAIN METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 225. SPAIN METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 226. SPAIN METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. DENMARK METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 267. DENMARK METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 268. DENMARK METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 269. DENMARK METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 270. DENMARK METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 271. DENMARK METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 272. DENMARK METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. DENMARK METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 274. DENMARK METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 275. DENMARK METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 276. DENMARK METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 277. DENMARK METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 278. DENMARK METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 292. QATAR METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 293. QATAR METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 294. QATAR METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 295. QATAR METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 296. QATAR METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 297. QATAR METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 298. QATAR METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. QATAR METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 300. QATAR METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 301. QATAR METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 302. QATAR METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 303. QATAR METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 304. QATAR METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 305. FINLAND METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 306. FINLAND METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 307. FINLAND METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 308. FINLAND METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 309. FINLAND METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 310. FINLAND METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 311. FINLAND METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. FINLAND METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 313. FINLAND METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 314. FINLAND METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 315. FINLAND METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 316. FINLAND METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 317. FINLAND METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 318. SWEDEN METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 319. SWEDEN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 320. SWEDEN METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 326. SWEDEN METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 327. SWEDEN METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 328. SWEDEN METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 329. SWEDEN METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 330. SWEDEN METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 331. NIGERIA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 336. NIGERIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 337. NIGERIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. NIGERIA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 339. NIGERIA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 340. NIGERIA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2030 (USD MILLION)
TABLE 341. NIGERIA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 342. NIGERIA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 343. NIGERIA METABOLOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 344. EGYPT METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 345. EGYPT METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 346. EGYPT METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 347. EGYPT METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 348. EGYPT METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 349. EGYPT METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 350. EGYPT METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 351. EGYPT METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 352. EGYPT METABOLOMICS MARKET SIZE, BY DRUG DIS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Metabolomics market report include:
  • Afekta Technologies Ltd.
  • BASF SE
  • Bio-Rad Laboratories, Inc.
  • Biocrates Life Science AG
  • Bruker Corporation
  • Clinical Microbiomics A/S
  • Danaher Corporation
  • DNA Xperts Private Limited
  • General Metabolics
  • Hitachi High-Tech Corporation
  • Human Metabolome Technologies Inc.
  • JASCO Corporation
  • Kore Technology Limited
  • LECO Corporation
  • Merck KGaA
  • Metabolon, Inc.
  • Shimadzu Corporation
  • Techcomp Europe Ltd
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.39 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.83 Billion
Compound Annual Growth Rate11.3%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Metabolomics Market Report 2025-2033 - Product Image

Metabolomics Market Report 2025-2033

  • Report
  • 143 Pages
  • Global
From
Metabolomics - Global Strategic Business Report - Product Image

Metabolomics - Global Strategic Business Report

  • Report
  • 415 Pages
  • Global
From
Metabolomics Market Report 2025 - Product Image

Metabolomics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Metabolomics Market - Technologies and Applications - Product Image

Metabolomics Market - Technologies and Applications

  • Report
  • 245 Pages
  • Global
From
Metabolomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Metabolomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.